We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICH Guideline on Evaluating Carcinogenic Risk Adopted in Both U.S. and Europe
ICH Guideline on Evaluating Carcinogenic Risk Adopted in Both U.S. and Europe
May 8, 2013
To minimize cancer risks, the U.S. Food and Drug Administration is adopting a draft global guideline on identification and control of mutagenic impurities in drugs using genotoxic or carcinogenic starting materials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor